For miR-497, it was reported to inhibit ovarian cancer cell migration and invasion through targeting of SMAD specific E3 ubiquitin protein ligase and modulate gastric cancer cell invasion by repressing eIF4E [25, 26]. Here, EIF4E is linked to gastric cancer.